Gregory S. Hageman, PhD

Research Interests

  • The Biology, Genetics and Development of Diagnostic and Therapeutic Modalities for the Treatment of Age-Related Macular Degeneration and its Co-Segregating Diseases

Languages

  • English

Academic Information

  • Departments: Ophthalmology/Visual Sciences - Professor

Academic Office Information

  • John A. Moran Eye Center
    Opthalmology-Services
    65 N Mario Capecchi
    Salt Lake City, UT 84132

Academic Bio

Gregory Hageman is the John A. Moran Presidential Endowed Chair and the Executive Director of the Moran Eye Center for Translational Medicine at the University of Utah Moran Eye Center. He is an active member of professional and honorary organizations, and has served on numerous national and international advisory boards, service panels, and review committees. He has also been an advisor to numerous pharmaceutical and diagnostic companies.


Dr. Hageman’s primary research interest for over 20 years has been directed toward assessment of pathways involved in the etiology of age-related macular degeneration (AMD). Dr. Hageman and his colleagues discovered that AMD is characterized by robust activation of the complement cascade in the ocular macula and that variations in complement genes, including Complement Factor H (CFH), account for greater than 50% of risk for AMD in Caucasians. More recent discoveries relate to the role of the choriocapillaris in severe forms of AMD and diseases that co-segregate with it. Dr. Hageman has twice briefed the US Congress on his research findings and has received numerous awards for his contributions to AMD research. A major goal of Dr. Hageman’s current efforts is to expedite the pace at which basic scientific discoveries are translated into clinically effective therapies for the treatment of AMD and its co-segregating diseases.
Greg and his wife, Jill, have been married 33 years. They have two wonderful children, Nicholas and Courtney.

Education History

Type School Degree
Doctoral Training University of Southern California
Biology
Ph.D.
Undergraduate University of Southern California
Biological Sciences
B.S.

Selected Publications

Journal Article

  1. Gorusupudi A, Liu A, Hageman GS, Bernstein PS (2016 Mar).

    Associations of human retinal very long-chain polyunsaturated fatty acids with dietary lipid biomarkers.

    . J Lipid Res, 57(3), 499-508.
  2. Keenan TD, Toso M, Pappas C, Nichols L, Bishop PN, Hageman GS (2015 Jul 1).

    Assessment of Proteins Associated With Complement Activation and Inflammation in Maculae of Human Donors Homozygous Risk at Chromosome 1 CFH-to-F13B.

    . Invest Ophthalmol Vis Sci, 56(8), 4870-9.
  3. Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH (2015).

    Fundus autofluorescence characteristics of nascent geographic atrophy in age-related macular degeneration.

    . Invest Ophthalmol Vis Sci, 56(3), 1546-52.
  4. Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH (2014 Dec).

    Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration.

    . Ophthalmology, 121(12), 2415-22.
  5. Finger RP, Wu Z, Luu CD, Kearney F, Ayton LN, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH (2014 Jun).

    Reticular pseudodrusen: a risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization.

    . Ophthalmology, 121(6), 1252-6.
  6. Bird AC, Phillips RL, Hageman GS (2014 Mar). Geographic atrophy: a histopathological assessment. JAMA Ophthalmol, 132(3), 338-45.
  7. Schaumberg DA, Rose L, DeAngelis MM, Semba RD, Hageman GS, Chasman DI (2014 Jan). Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies. JAMA Ophthalmol, 132(1), 84-95.
  8. Xu L, Blonska AM, Pumariega NM, Bearelly S, Sohrab MA, Hageman GS, Smith RT (2013 Oct). Reticular macular disease is associated with multilobular geographic atrophy in age-related macular degeneration. Retina, 33(9), 1850-62.
  9. Perlee LT, Bansal AT, Gehrs K, Heier JS, Csaky K, Allikmets R, Oeth P, Paladino T, Farkas DH, Rawlings PL, Hageman GS (2013 Sep). Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy. Ophthalmology, 120(9), 1880-92.
  10. Ahmed F, Kamae KK, Jones DJ, Deangelis MM, Hageman GS, Gregory MC, Bernstein PS (2013 Jun). Temporal macular thinning associated with X-linked Alport syndrome. JAMA Ophthalmol, 131(6), 777-82.
  11. Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR (2013 Apr). Clinical classification of age-related macular degeneration. Ophthalmology, 120(4), 844-51.
  12. Fritsche, LG, et al Gregory S Hageman author (). For the AMD gene Consortium (2013). Seven new loci associated with age-related macular degeneration. Nat Genet, 45(4), 433-9.
  13. Meyers KJ, Johnson EJ, Bernstein PS, Iyengar SK, Engelman CD, Karki CK, Liu Z, Igo RP Jr, Truitt B, Klein ML, Snodderly DM, Blodi BA, Gehrs KM, Sarto GE, Wallace RB, Robinson J, LeBlanc ES, Hageman G, Tinker L, Mares JA (2013 Mar). Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study. Invest Ophthalmol Vis Sci, 54(3), 2333-45.
  14. Cherepanoff S, Killingsworth MC, Zhu M, Nolan T, Hunyor AP, Young SH, Hageman GS, Gillies MC (2012 Nov). Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia. Br J Ophthalmol, 96(11), 1404-9.
  15. Lim JH, Wickremasinghe SS, Xie J, Chauhan DS, Baird PN, Robman LD, Hageman G, Guymer RH (2012 Apr). Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration. Am J Ophthalmol, 153(4), 678-86, 686.e1-2.
  16. Len AC, Powner MB, Zhu L, Hageman GS, Song X, Fruttiger M, Gillies MC (2012 Feb 3). Pilot application of iTRAQ to the retinal disease Macular Telangiectasia. J Proteome Res, 11(2), 537-53.
  17. Lim JH, Wickremasinghe SS, Xie J, Chauhan DS, Baird PN, Robman LD, Hageman GS, Guymer RH (). Delay to treatment and visual outcomes in patients treated wiht anti-vascular endothelial growth factor for age-related macular degeneration. Am J Ophthalmol, 153(4), 678-86.
  18. Newman AM, Gallo NB, Hancox LS, Miller NJ, Radeke CM, Maloney MA, Cooper JB, Hageman GS, Anderson DH, Johnson LV, Radeke MJ (2012). Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Medicine, 4(2), 16.
  19. Baas DC, Ho L, Tanck MW, Fritsche LG, Merriam JE, van het Slot R, Koeleman BP, Gorgels TG, van Duijn CM, Uitterlinden AG, de Jong PT, Hofman A, ten Brink JB, Vingerling JR, Klaver CC, Dean M, Weber BH, Allikmets R, Hageman GS, Bergen AA (2012). Multicenter cohort association study of SLC2A1 single nucleotide polymorphisms and age-related macular degeneration. Mol Vis, 18, 657-74.
  20. Morrison MA, Silveira AC, Huynh N, Jun G, Smith SE, Zacharaki F, Sato H, Loomis S, Andreoli MT, Adams SM, Radeke MJ, Jelcick AS, Yuan Y, Tsiloulis AN, Chatzoulis DZ, Silvestri G, Kotoula MG, Tsironi EE, Hollis BW, Chen R, Haider NB, Miller JW, Farrer LA, Hageman GS, Kim IK, Schaumberg DA, DeAngelis MM (2011 Oct). Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics, 5(6), 538-68.
  21. Hageman GS, Gehrs K, Lejnine S, Bansal AT, Deangelis MM, Guymer RH, Baird PN, Allikmets R, Deciu C, Oeth P, Perlee LT (2011 Jul). Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration. Hum Genomics, 5(5), 420-40.
  22. Powner MB, Scott A, Zhu M, Munro P, Foss A, Hageman GS, Gillies M, Fruttiger M (). Basement membrane changes in capillaries of the ageing human retina. Br J Ophthalmol, 95(9), 1316-22.
  23. Fleckenstein M, Schmitz-Valckenberg S, Martens C, Kosanetzky S, Brinkmann CK, Hageman GS, Holz FG (2011 May). Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy. Invest Ophthalmol Vis Sci, 52(6), 3761-6.
  24. Millen AE, Voland R, Sondel SA, Parekh N, Horst RL, Wallace RB, Hageman GS, Chappell R, Blodi BA, Klein ML, Gehrs KM, Sarto GE, Mares JA (2011 Apr). Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol, 129(4), 481-9.
  25. Wickremasinghe SS, Xie J, Lim J, Chauhan DS, Robman L, Richardson AJ, Hageman G, Baird PN, Guymer R (). Variants in the APOE Gene are Associated with Improved Treatment Outcome Following Anti-VEGF Therapy for Neovascular AMD. Invest Ophthalmol Vis Sci, 52(7), 4072-4079.
  26. Gupta P, Yee KM, Garcia P, Rosen RB, Parikh J, Hageman GS, Sadun AA, Sebag J (2011 Mar). Vitreoschisis in macular diseases. Br J Ophthalmol, 95(3), 376-80.
  27. Haas P, Steindl K, Aggermann T, Schmid-Kubista K, Krugluger W, Hageman GS, Binder S (2011 Feb). Serum VEGF and CFH in exudative age-related macular degeneration. Curr Eye Res, 36(2), 143-8.
  28. Baehr W, Wensel T, Hageman GS, Wu S, Zack D (). Retinal Ganglion Cells: Development, Function, and Disease. Vision Res, 51(2), 223.
  29. Jun G, Nicolaou M, Morrison MA, Buros J, Morgan DJ, Radeke MJ, Yonekawa Y, Tsironi EE, Kotoula MG, Zacharaki F, Mollema N, Yuan Y, Miller JW, Haider NB, Hageman GS, Kim IK, Schaumberg DA, Farrer LA, DeAngelis MM (2011). Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. PLoS ONE, 6(10), e25775.
  30. Baehr W, Hageman GS, Wensen T, Wu S, Zack D (). Mechanisms of macular degeneration. Vision Res, 50(7), 637.
  31. Powner MB, Gillies MC, Tretiach M, Scott A, Guymer RH, Hageman GS, Fruttiger M (2010 Dec). Perifoveal muller cell depletion in a case of macular telangiectasia type 2. Ophthalmology, 117(12), 2407-16.
  32. Kelly U, Yu L, Kumar P, Ding JD, Jiang H, Hageman GS, Arshavsky VY, Frank MM, Hauser MA, Rickman CB (2010 Nov 1). Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration. J Immunol, 185(9), 5486-94.
  33. Edelhauser HF, Rowe-Rendleman CL, Robinson MR, Dawson DG, Chader GJ, Grossniklaus HE, Rittenhouse KD, Wilson CG, Weber DA, Kuppermann BD, Csaky KG, Olsen TW, Kompella UB, Holers VM, Hageman GS, Gilger BC, Campochiaro PA, Whitcup SM, Wong WT (2010 Nov). Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci, 51(11), 5403-20.
  34. Silveira AC, Morrison MA, Ji F, Xu H, Reinecke JB, Adams SM, Arneberg TM, Janssian M, Lee JE, Yuan Y, Schaumberg DA, Kotoula MG, Tsironi EE, Tsiloulis AN, Chatzoulis DZ, Miller JW, Kim IK, Hageman GS, Farrer LA, Haider NB, DeAngelis MM (2010 Mar 31). Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vision Res, 50(7), 698-715.
  35. Savige J, Liu J, DeBuc DC, Handa JT, Hageman GS, Wang YY, Parkin JD, Vote B, Fassett R, Sarks S, Colville D (2010 Mar). Retinal basement membrane abnormalities and the retinopathy of Alport syndrome. Invest Ophthalmol Vis Sci, 51(3), 1621-7.
  36. Haas P, Steindl K, Schmid-Kubista KE, Aggermann T, Krugluger W, Hageman GS, Binder S (2009 Dec). Complement factor H gene polymorphisms and Chlamydia pneumoniae infection in age-related macular degeneration. Eye (Lond), 23(12), 2228-32.
  37. Kelly U, Rickman CB, Postel EA, Hauser MA, Hageman GS, Arshavsky VY, Skiba NP (2009 Apr). Rapid and sensitive method for detection of Y402, H402, I62, and V62 variants of complement factor H in human plasma samples using mass spectrometry. Invest Ophthalmol Vis Sci, 50(4), 1540-5.
  38. Barlow PN, Hageman GS, Lea SM (2008). Complement factor H: using atomic resolution structure to illuminate disease mechanisms. Adv Exp Med Biol, 632, 117-42.
  39. Smith RJ, Alexander J, Barlow PN, Botto M, Cassavant TL, Cook HT, de Cordoba SR, Hageman GS, Jokiranta TS, Kimberling WJ, Lambris JD, Lanning LD, Levidiotis V, Licht C, Lutz HU, Meri S, Pickering MC, Quigg RJ, Rops AL, Salant DJ, Sethi S, Thurman JM, Tully HF, Tully SP, van der Vlag J, Walker PD, Wurzner R, Zipfel PF (2007 Sep). New approaches to the treatment of dense deposit disease. J Am Soc Nephrol, 18(9), 2447-56.
  40. Laine M, Jarva H, Seitsonen S, Haapasalo K, Lehtinen MJ, Lindeman N, Anderson DH, Johnson PT, Jarvela I, Jokiranta TS, Hageman GS, Immonen I, Meri S (2007 Mar 15). Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol, 178(6), 3831-6.
  41. Johnson PT, Betts KE, Radeke MJ, Hageman GS, Anderson DH, Johnson LV (2006 Nov 14). Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A, 103(46), 17456-61.
  42. Abrera-Abeleda MA, Nishimura C, Smith JL, Sethi S, McRae JL, Murphy BF, Silvestri G, Skerka C, Jozsi M, Zipfel PF, Hageman GS, Smith RJ (2006 Jul). Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet, 43(7), 582-9.
  43. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, Hageman GS, Dean M, Allikmets R (2006 Apr). Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet, 38(4), 458-62.
  44. Donoso LD, Kim D, Frost A, Callahan A, Hageman GS (2006). The Role of Inflammation in the Pathogenesis of Age-related Macular Degeneration. Surv Ophthalmol, 51(2), 137-152.
  45. Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV, Radeke MJ, Kavanagh D, Richards A, Atkinson J, Meri S, Bergeron J, Zernant J, Merriam J, Gold B, Allikmets R, Dean M (2006). Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med, 38(8), 592-604.
  46. Abrera-Abeleda MA, Nishimura C, Smith JLH, Sethi S, McRae JL, Murphy BF, Silvestri G, Skerka C, Jozsi M, Zipfel PF, Hageman GS, Smith RJH (2005). Variations in the Complement Regulatory Genes Factor H (CFH) and Factor H Related 5 (CFHR5) are Associated with Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease). J Med Genet, 43, 582-589.
  47. Mullins RF, Oh KT, Heffron E, Hageman GS, Stone EM (2005 Nov). Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation. Arch Ophthalmol, 123(11), 1588-94.
  48. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R (2005 May 17). A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A, 102(20), 7227-32.
  49. MPGN II Focus Group Appel GB, Cook HT, Hageman GS, Jennette C, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJH, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Wurzner R, Zipfel PF (2005). Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update. J Am Soc Nephrol, 16(5), 1392-403.
  50. Chong NH, Keonin J, Luthert PJ, Frennesson CI, Weingeist DM, Wolf RL, Mullins RF, Hageman GS (2005 Jan). Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration. Am J Pathol, 166(1), 241-51.
  51. Guymer RH, Bird AC, Hageman GS (2004 Jun). Cytoarchitecture of choroidal capillary endothelial cells. Invest Ophthalmol Vis Sci, 45(6), 1660-6.
  52. Russell SR, Gupta RR, Folk JC, Mullins RF, Hageman GS (2004 May). Comparison of color to fluorescein angiographic images from patients with early-adult onset grouped drusen suggests drusen substructure. Am J Ophthalmol, 137(5), 924-30.
  53. Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV (2004 Feb). Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res, 78(2), 243-56.
  54. Donoso LA, Hageman G, Frost A, Sheffield V, Beck J, Hebert M, MacDonald IM (2003 Feb). Autosomal dominant macular dystrophy in a large Canadian family. Can J Ophthalmol, 38(1), 33-40.
  55. Donoso LA, Hageman GS, Frost A, Sheffield VC, Beck J, MacDonald IM (2003). Autosomal dominant macular dystrophy in a large Canadian family. Can J Ophthalmol, 38, 33-40.
  56. Kinkl N, Hageman GS, Sahel JA, Hicks D (2002 Jun 14). Fibroblast growth factor receptor (FGFR) and candidate signaling molecule distribution within rat and human retina. Mol Vis, 8, 149-60.
  57. Kuehn MH, Stone EM, Hageman GS (2001 Dec). Organization of the human IMPG2 gene and its evaluation as a candidate gene in age-related macular degeneration and other retinal degenerative disorders. Invest Ophthalmol Vis Sci, 42(13), 3123-9.
  58. Russell SR, Hageman GS (2001 Nov). Optic disc, foveal, and extrafoveal damage due to surgical separation of the vitreous. Arch Ophthalmol, 119(11), 1653-8.
  59. Donoso LA, Edwards AO, Frost A, Vrabec T, Stone EM, Hageman GS, Perski T (2001 Sep-Oct). Autosomal dominant Stargardt-like macular dystrophy. Surv Ophthalmol, 46(2), 149-63.
  60. Alagramam KN, Yuan H, Kuehn MH, Murcia CL, Wayne S, Srisailpathy CR, Lowry RB, Knaus R, Van Laer L, Bernier FP, Schwartz S, Lee C, Morton CC, Mullins RF, Ramesh A, Van Camp G, Hageman GS, Woychik RP, Smith RJ (2001 Aug 1). Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet, 10(16), 1709-18.
  61. Mullins RF, Aptsiauri N, Hageman GS (2001 Jun). Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye (Lond), 15(Pt 3), 390-5.
  62. Anderson DH, Ozaki S, Nealon M, Neitz J, Mullins RF, Hageman GS, Johnson LV (2001 Jun). Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol, 131(6), 767-81.
  63. Clark AF, Kawase K, English-Wright S, Lane D, Steely HT, Yamamoto T, Kitazawa Y, Kwon YH, Fingert JH, Swiderski RE, Mullins RF, Hageman GS, Alward WL, Sheffield VC, Stone EM (2001 May). Expression of the glaucoma gene myocilin (MYOC) in the human optic nerve head. FASEB J, 15(7), 1251-3.
  64. Donoso LA, Frost AT, Stone EM, Weleber RG, MacDonald IM, Hageman GS, Cibis GW, Ritter R 3rd, Edwards AO (2001 Apr). Autosomal dominant Stargardt-like macular dystrophy: founder effect and reassessment of genetic heterogeneity. Arch Ophthalmol, 119(4), 564-70.
  65. Ruiz A, Kuehn MH, Andorf JL, Stone E, Hageman GS, Bok D (2001 Jan). Genomic organization and mutation analysis of the gene encoding lecithin retinol acyltransferase in human retinal pigment epithelium. Invest Ophthalmol Vis Sci, 42(1), 31-7.
  66. Jacobson N, Andrews M, Shepard AR, Nishimura D, Searby C, Fingert JH, Hageman GS, Mullins R, Davidson BL, Kwon YK, Alward WLM, Stone EM, Clark AF, Sheffield VC (2001). Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet, 10, 117-125.
  67. Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002). A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol, 134, 411-431.
  68. Guymer RH, Hageman GS, Bird AC (2001 Jan). Influence of laser photocoagulation on choroidal capillary cytoarchitecture. Br J Ophthalmol, 85(1), 40-6.
  69. Pager CK, Sarin LK, Federman JL, Eagle R, Hageman GS, Rosenow J, Donoso LA (2001). Malattia leventinese presenting with subretinal neovascular membrane and hemorrhage. Am J Ophthalmol, 131, 517-518.
  70. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF (). An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res, 20(6), 705-32.
  71. Hawes NL, Chang B, Hageman GS, Nusinowitz S, Nishina PM, Schneider BS, Smith RS, Roderick TH, Davisson MT, Heckenlively JR (2000 Sep). Retinal degeneration 6 (rd6): a new mouse model for human retinitis punctata albescens. Invest Ophthalmol Vis Sci, 41(10), 3149-57.
  72. Kuehn MH, Wietecki DT, Hageman GS (2000 Aug 24). Molecular characterization of the murine orthologue of the human retinal proteoglycan IPM 150. Mol Vis, 6, 148-56.
  73. Mullins RF, Russell SR, Anderson DH, Hageman GS (2000 May). Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J, 14(7), 835-46.
  74. Yarovinsky TO, Rickman DW, Diamond RH, Taub R, Hageman GS, Bowes Rickman C (2000 Apr 14). Expression of the protein tyrosine phosphatase, phosphatase of regenerating liver 1, in the outer segments of primate cone photoreceptors. Brain Res Mol Brain Res, 77(1), 95-103.
  75. Russell SR, Mullins RF, Schneider BL, Hageman GS (2000 Feb). Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am J Ophthalmol, 129(2), 205-14.
  76. Mullins RF, Hageman GS (1999 Dec). Human ocular drusen possess novel core domains with a distinct carbohydrate composition. J Histochem Cytochem, 47(12), 1533-40.
  77. Anderson DH, Hageman GS, Mullins RF, Neitz M, Neitz J, Ozaki S, Preissner KT, Johnson LV (1999 Dec). Vitronectin gene expression in the adult human retina. Invest Ophthalmol Vis Sci, 40(13), 3305-15.
  78. Hageman GS, Mullins RF (1999 Nov 3). Molecular composition of drusen as related to substructural phenotype. Mol Vis, 5, 28.
  79. Kuehn MH, Hageman GS (1999 Oct). Expression and characterization of the IPM 150 gene (IMPG1) product, a novel human photoreceptor cell-associated chondroitin-sulfate proteoglycan. Matrix Biol, 18(5), 509-18.
  80. Kuehn MH, Hageman GS (1999 Aug). Molecular characterization and genomic mapping of human IPM 200, a second member of a novel family of proteoglycans. Mol Cell Biol Res Commun, 2(2), 103-10.
  81. Stone EM, Lotery AJ, Munier FL, Heon E, Piguet B, Guymer RH, Vandenburgh K, Cousin P, Nishimura D, Swiderski RE, Silvestri G, Mackey DA, Hageman GS, Bird AC, Sheffield VC, Schorderet DF (1999 Jun). A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet, 22(2), 199-202.
  82. Ozaki S, Johnson LV, Mullins RF, Hageman GS, Anderson DH (1999 May 19). The human retina and retinal pigment epithelium are abundant sources of vitronectin mRNA. Biochem Biophys Res Commun, 258(3), 524-9.
  83. Hageman GS, Mullins RF, Russell SR, Johnson LV, Anderson DH (1999 Mar). Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J, 13(3), 477-84.
  84. Abdala CA, Meredith TA, Aguilar HE, Liang CP, Hageman GS (1998). Repeated intravitreal injections of vancomycin or ceftazidime do not elicit retinal toxicity. Am J Ophthalmol.
  85. Russell SR, Hageman GS (1997 Mar). Insoluble interphotoreceptor matrix in human vitreous after rhegmatogenous retinal detachment. Am J Ophthalmol, 123(3), 386-91.
  86. Mullins RF, Johnson LV, Anderson DH, Hageman GS (1997 Feb). Characterization of drusen-associated glycoconjugates. Ophthalmology, 104(2), 288-94.
  87. Meyer JC, Quantock AJ, Thonar EJ, Kincaid MC, Hageman GS, Assil KK (1996 Jul). Characterization of a central corneal cloudiness sharing features of posterior crocodile shagreen and central cloud dystrophy of Francois. Cornea, 15(4), 347-54.
  88. Lazarus HS, Schoenfeld CL, Fekrat S, Cohen S, Carol A, Hageman GS, Hackett S, Chen YS, Vinores SA, Campochiaro PA (1996 Jun). Hyalocytes synthesize and secrete inhibitors of retinal pigment epithelial cell proliferation in vitro. Arch Ophthalmol, 114(6), 731-6.
  89. Sires BS, Holds JB, Archer CR, Kincaid MC, Hageman GS (1995 Dec). Histological and radiological analyses of hydroxyapatite orbital implants in rabbits. Ophthal Plast Reconstr Surg, 11(4), 273-7.
  90. Heckenlively JR, Chang B, Erway LC, Peng C, Hawes NL, Hageman GS, Roderick TH (1995 Nov 21). Mouse model for Usher syndrome: linkage mapping suggests homology to Usher type I reported at human chromosome 11p15. Proc Natl Acad Sci U S A, 92(24), 11100-4.
  91. Anderson DH, Johnson LV, Hageman GS (1995 Sep 11). Vitronectin receptor expression and distribution at the photoreceptor-retinal pigment epithelial interface. J Comp Neurol, 360(1), 1-16.
  92. Anderson DH, Guerin CJ, Hageman GS, Pfeffer BA, Flanders KC (1995 Sep 1). Distribution of transforming growth factor-beta isoforms in the mammalian retina. J Neurosci Res, 42(1), 63-79.
  93. Hageman GS, Marmor MF, Yao XY, Johnson LV (1995 May). The interphotoreceptor matrix mediates primate retinal adhesion. Arch Ophthalmol, 113(5), 655-60.
  94. Hageman GS, Marmor MF, Yao XY, Johnson LV (1995). La matrix interfortorreceptora media la adhesión retiniana del primate. Arch Ophthalmol (Spanish edition), 6(5), 274-280.
  95. Lazarus HS, Hageman GS (1994 Oct). In situ characterization of the human hyalocyte. Arch Ophthalmol, 112(10), 1356-62.
  96. Sender S, Gros G, Waheed A, Hageman GS, Sly WS (1994 Sep). Immunohistochemical localization of carbonic anhydrase IV in capillaries of rat and human skeletal muscle. J Histochem Cytochem, 42(9), 1229-36.
  97. Chang B, Bronson RT, Hawes NL, Roderick TH, Peng C, Hageman GS, Heckenlively JR (1994 Mar). Retinal degeneration in motor neuron degeneration: a mouse model of ceroid lipofuscinosis. Invest Ophthalmol Vis Sci, 35(3), 1071-6.
  98. Yao XY, Hageman GS, Marmor MF (1994 Feb). Retinal adhesiveness in the monkey. Invest Ophthalmol Vis Sci, 35(2), 744-8.
  99. Marmor MF, Yao XY, Hageman GS (1994). Retinal adhesiveness in surgically enucleated human eyes. Retina, 14(2), 181-6.
  100. Blanks JC, Johnson LV, Hageman GS (1993 Sep). Stage-specific binding of peanut agglutinin to aggregates of degenerating photoreceptor cells in the rd mouse retina. Exp Eye Res, 57(3), 265-73.
  101. Mantych GJ, Hageman GS, Devaskar SU (1993 Aug). Characterization of glucose transporter isoforms in the adult and developing human eye. Endocrinology, 133(2), 600-7.
  102. Bloom JN, Ni M, Moore TL, Osborn TG, Hageman GS (1993 Jul-Aug). Serum antiocular antibodies in patients with juvenile rheumatoid arthritis. J Pediatr Ophthalmol Strabismus, 30(4), 243-8.
  103. Lazarus HS, Sly WS, Kyle JW, Hageman GS (1993 May). Photoreceptor degeneration and altered distribution of interphotoreceptor matrix proteoglycans in the mucopolysaccharidosis VII mouse. Exp Eye Res, 56(5), 531-41.
  104. Russell SR, Hageman GS (1992 Jul). Chondroitin sulfate-induced generation of epiretinal membranes. Arch Ophthalmol, 110(7), 1000-6.
  105. Korte GE, Hageman GS, Pratt DV, Glusman S, Marko M, Ophir A (1992 Jul). Changes in Muller cell plasma membrane specializations during subretinal scar formation in the rabbit. Exp Eye Res, 55(1), 155-62.
  106. Kratz-Owens KL, Hageman GS, Schanzlin DJ (1992 May-Jun). An in-vivo technique for monitoring keratocyte migration following lamellar keratoplasty. Refract Corneal Surg, 8(3), 230-4.
  107. Yao XY, Hageman GS, Marmor MF (1992 Mar). Recovery of retinal adhesion after enzymatic perturbation of the interphotoreceptor matrix. Invest Ophthalmol Vis Sci, 33(3), 498-503.
  108. Lazarus HS, Hageman GS (1992 Feb). Xyloside-induced disruption of interphotoreceptor matrix proteoglycans results in retinal detachment. Invest Ophthalmol Vis Sci, 33(2), 364-76.
  109. Russell SR, Hageman GS (1992). Hemorrhagic detachment of the internal limiting membrane after penetrating ocular injury. Retina, 12(4), 346-50.
  110. Hageman GS, Kirchoff-Rempe MA, Lewis GP, Fisher SK, Anderson DH (1991 Aug 1). Sequestration of basic fibroblast growth factor in the primate retinal interphotoreceptor matrix. Proc Natl Acad Sci U S A, 88(15), 6706-10.
  111. Russell SR, Shepherd JD, Hageman GS (1991 Jun). Distribution of glycoconjugates in the human retinal internal limiting membrane. Invest Ophthalmol Vis Sci, 32(7), 1986-95.
  112. Johnson LV, Hageman GS (1991 Jun). Structural and compositional analyses of isolated cone matrix sheaths. Invest Ophthalmol Vis Sci, 32(7), 1951-7.
  113. Hageman GS, Zhu XL, Waheed A, Sly WS (1991 Apr 1). Localization of carbonic anhydrase IV in a specific capillary bed of the human eye. Proc Natl Acad Sci U S A, 88(7), 2716-20.
  114. Hageman GS, Johnson LV (1991). Structure, composition and function of the retinal interphotoreceptor matrix. Prog Retin Eye Res, 10, 207-249.
  115. Yao XY, Hageman GS, Marmor MF (1990 Oct). Retinal adhesiveness is weakened by enzymatic modification of the interphotoreceptor matrix in vivo. Invest Ophthalmol Vis Sci, 31(10), 2051-8.
  116. Rohlich P, Szel A, Johnson LV, Hageman GS (1989 Nov 15). Carbohydrate components recognized by the cone-specific monoclonal antibody CSA-1 and by peanut agglutinin are associated with red and green-sensitive cone photoreceptors. J Comp Neurol, 289(3), 395-400.
  117. Johnson LV, Blanks JC, Hageman GS (1989). Effects of retinal degenerations on the cone matrix sheath. Prog Clin Biol Res, 314, 217-32.
  118. Blanks JC, Hageman GS, Johnson LV, Spee C (1988 Apr 8). Ultrastructural visualization of primate cone photoreceptor matrix sheaths. J Comp Neurol, 270(2), 288-300.
  119. Johnson LV, Hageman GS (1988 Apr). Characterization of molecules bound by the cone photoreceptor-specific monoclonal antibody CSA-1. Invest Ophthalmol Vis Sci, 29(4), 550-7.
  120. Hageman GS, Johnson LV (1987 Apr). Chondroitin 6-sulfate glycosaminoglycan is a major constituent of primate cone photoreceptor matrix sheaths. Curr Eye Res, 6(4), 639-46.
  121. Johnson LV, Hageman GS (1987 Apr). Enzymatic characterization of peanut agglutinin-binding components in the retinal interphotoreceptor matrix. Exp Eye Res, 44(4), 553-65.
  122. Blanks JC, Hageman GS, Johnson LV (1987). Appearance of PNA-binding cells within the outer nuclear layer coinciding with photoreceptor degeneration in rd mice. Prog Clin Biol Res, 247, 229-42.
  123. Hageman GS, Schmidt SY (1987). Taurine-deficient pigmented and albino rats: early retinal abnormalities and differential rates of photoreceptor degeneration. Prog Clin Biol Res, 247, 497-515.
  124. Hageman GS, Johnson LV (1986 Jul 22). Biochemical characterization of the major peanut-agglutinin-binding glycoproteins in vertebrate retinae. J Comp Neurol, 249(4), 499-510, 482-3.
  125. Johnson LV, Hageman GS, Blanks JC (1986 Feb). Interphotoreceptor matrix domains ensheath vertebrate cone photoreceptor cells. Invest Ophthalmol Vis Sci, 27(2), 129-35.
  126. Johnson LV, Hageman GS, Blanks JC (1986). Interphotoreceptor matrix domains ensheath cone photoreceptors in vertebrate retinae. Prog Clin Biol Res, 190, 33-44.
  127. Johnson LV, Hageman GS, Blanks JC (1985). Restricted extracellular matrix domains ensheath cone photoreceptors in vertebrate retinae. Prog Clin Biol Res, 190, 33-44.
  128. Hageman GS, Kelly DE (1984). Fibrillar and cytoskeletal substructure of tight junctions: analysis of single-stranded tight junctions linking fibroblasts of the lamina fusca in hamster eyes. Cell Tissue Res, 238(3), 545-57.
  129. Kelly DE, Hageman GS, McGregor JA (1983 Sep). Uveal compartmentalization in the hamster eye revealed by fine structural and tracer studies: implications for uveoscleral outflow. Invest Ophthalmol Vis Sci, 24(9), 1288-304.
  130. Wood RL, Hageman GS (1982 May). The fine structure of cellular junctions in a marine bryozoan: gap junctions. J Ultrastruct Res, 79(2), 174-88.
  131. Hageman GS, Lutaud G (1982). La structure des organes perioperculaires des chilostomes malacosteges et leur relation avec le reseau parietal chez Membranipora. Cah Biol Mar, 23, 347-357.
  132. Butler JL, Moser HG, Hageman GS, Nordgren LE (1982). Developmental stages of three California sea basses (Paralabrax, Pisces, Serranidae). Rep Calif Cooper Ocean Fish Investig, 23, 252-268.

Review

  1. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright JN, Malek G, Hauser MA, Rickman CB, Bok D, Hageman GS, Johnson LV (2010 Mar). The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. [Review]. Prog Retin Eye Res, 29(2), 95-112.
  2. Gehrs KM, Jackson JR, Brown EN, Allikmets R, Hageman GS (2010 Mar). Complement, age-related macular degeneration and a vision of the future. [Review]. Arch Ophthalmol, 128(3), 349-58.
  3. Baird PN, Hageman GS, Guymer RH (2009 Nov). New era for personalized medicine: the diagnosis and management of age-related macular degeneration. [Review]. Clin Exp Ophthalmol, 37(8), 814-21.
  4. Donoso LA, Kim D, Frost A, Callahan A, Hageman G (2006 Mar-Apr). The role of inflammation in the pathogenesis of age-related macular degeneration. [Review]. Surv Ophthalmol, 51(2), 137-52.
  5. Gehrs KM, Anderson DH, Johnson LV, Hageman GS (2006). Age-related macular degeneration--emerging pathogenetic and therapeutic concepts. [Review]. Ann Med, 38(7), 450-71.
  6. Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Wurzner R, Zipfel PF (2005 May). Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. [Review]. J Am Soc Nephrol, 16(5), 1392-403.
  7. Stone EM, Sheffield VC, Hageman GS (2001 Oct 1). Molecular genetics of age-related macular degeneration. [Review]. Hum Mol Genet, 10(20), 2285-92.
  8. Gorin MB, Breitner JC, De Jong PT, Hageman GS, Klaver CC, Kuehn MH, Seddon JM (1999 Nov 3). The genetics of age-related macular degeneration. [Review]. Mol Vis, 5, 29.
  9. Bok D, Hageman GS, Steinberg RH (1993 Apr). Repair and replacement to restore sight. Report from the Panel on Photoreceptor/Retinal Pigment Epithelium. [Review]. Arch Ophthalmol, 111(4), 463-71.

Book

  1. Sebag J, Hageman GS (2001). Interfaces. Monograph, 81 pp., Fondazione G. B. Bietti a Roma Per lo Studio e la Ricerca in Oftalmologia. Rome: Farina Publishers.

Book Chapter

  1. Hageman GS, Gehrs K, Johnson LV, Anderson D (2008). Age-Related Macular Degeneration. In Kolb H, Fernandez E, Nelson R (Eds.), Webvision, The Organization of the Retina and Visual System (http://webvision.med.utah.edu/). John Moran Eye Center, University of Utah.
  2. Hageman GS, Mullins RF (2007). Association of major histocompatibility class II antigens with core subdomaims present within human ocular drusen. In Zierhut M, Rammensee H-G, Streilein W (Eds.), Antigen-presenting Cells and the Eye (pp. 209-216). New York/London: Taylor & Francis Group.
  3. Hageman GS, Johnson LV (2006). The photoreceptor - retinal pigmented epithelium interface. In Heckenlively JR, Arden GB (Eds.), Principles and Practice of Clinical Electrophysiology of Vision (2nd edition, pp. 23-36). St. Louis, MO: Mosby Year Book Publishers.
  4. Hageman GS, Kuehn MH (1998). Biology of the interphotoreceptor matrix-RPE-retina interface. In Marmor MF, Wolfensberger TJ (Eds.), Retinal Pigment Epithelium: Current Aspects of Function and Disease (pp. 361-391). Stanford, CA: Oxford University Press.
  5. Mullins RF, Hageman GS (1997). Histochemical comparison of ocular “drusen” in monkey and human. In LaVail M, Hollyfield JG, Anderson RE (Eds.), Degenerative Retinal Diseases (pp. 1-10). New York, NY: Plenum Press.
  6. Hageman GS, Gehrs K, Johnson LV, Anderson D (1995). Age-Related Macular Degeneration (AMD)BTI - Webvision: The Organization of the Retina and Visual System. Salt Lake City (UT).
  7. Hageman GS, Johnson LV (1991). The photoreceptor - retinal pigmented epithelium interface. In Heckenlively JR, Arden GB (Eds.), Principles and Practices of Clinical Electrophysiology of Vision (pp. 53-68). St. Louis, MO: Mosby Year Book Publishers.
  8. Johnson LV, Blanks JC, Hageman GS (1989). Effects of retinal degeneration on the cone matrix sheath. In LaVail MM, Hollyfield JG, Anderson RE (Eds.), Inherited and Environmentally Induced Retinal Degenerations (pp. 217-232). New York, NY: Alan R. Liss, Inc.

Editorial

  1. Baehr W, Wensel T, Hageman G, Wu S, Zack D (2011 Jan 28). Retinal ganglion cells: development, function, and disease. Vision Res, 51(2), 223.
  2. Sebag J, Hageman GS (2000 Jan-Mar). Interfaces. Utah Special Educator, 10(1), 1-3.

Letter

  1. Allikmets R, Dean M, Hageman GS, Baird PN, Klaver CC, Bergen AA, Weber BH (2009 Sep 12). The SERPING1 gene and age-related macular degeneration [Letter to the editor]. Lancet, 374(9693), 875-6; author reply 876-7.
  2. Allikmets R, Bergen AA, Dean M, Guymer RH, Hageman GS, Klaver CC, Stefansson K, Weber BH (2009 May 21). Geographic atrophy in age-related macular degeneration and TLR3 [Letter to the editor]. N Engl J Med, 360(21), 2252-4; author reply 2255-6.

Abstract

  1. Bernstein PS, Gorusupudi A, Liu A, Hageman GS (). The Role of Very Long Chain Polyunsaturated Fatty Acids (VLC-PUFAs) in Dry Age-Related Macular Degeneration (AMD) [Abstract]. Arnold and Mabel Beckman Initiative for Macular Research.
  2. Christiansen SM, Wirostko BM, Curtin K, Hageman GS (). Systemic Comorbidities of Pseudoexfoliative Glaucoma in the Utah Population [Abstract]. ARVO.
  3. Perlee L, Gehrs K, Hageman GS, Heier J, Csaky T, Oeth P, Paladino T, Farkas D, Rawlings L, Allikmets R (). Combining Genotype and Phenotype to Predict Progression to Choroidal Neovascularization (CNV) in Patients with AMD [Abstract]. American Academy of Ophthalmology.
  4. Hageman GS (). An Integrated Hypothesis of the Development and Progression of Age-related Macular Degeneration Based Upon Available Genetic and Biological Data [Abstract]. The American Society for Human Genetics.
  5. Karki C, Iyengar SK, Truitt B, Igo RP, Johnson E, Tinker L, Meyers KJ, and Mares JA for the CAREDS Investigators (). Genetic Determinants of Serum Lutein and Zeaxanthin Levels in the Carotenoids in Age-Related Eye Diseases Study [Abstract]. The Association for Research in Vision and Ophthalmology.
  6. Meyers KJ, Johnson EJ, Iyengar SK, Igo RP, Snodderly M, Klein ML, Bernstein PS, Millen AE, Hageman GS, Mares JA (). Genetic Determinants of Macular Pigment Optical Density in the Carotenoids in Age-Related Eye Diseases Study (CAREDS) [Abstract]. Investigative Ophthalmology and Visual Science.
  7. Hageman GS (). "Drusen": Harbingers of AMD-associated Pathways and Genes [Abstract]. Macula of Paris, 6th International Congress on AMD.
  8. DeAngelis M, Morrison MA, Silveira AC, Adams MC, Kotoula MG, Tsironi EE, Zacharaki F, Kim IK, Miller JW, Haider NB, Jelcick A, Hollis BW, Chen R, Hageman GS, Schaumberg DA (). Genetic Data Suggest a Novel Associaton Between the Vitamin D Pathway and Development of Age-related Macular Degeneration [Abstract]. The American Society of Human Genetics.
  9. Schu M, Jun G, Morrison MA, Farrell J, Kim IK, Morgan DJ, Hageman GS, Farrer LA, DeAngelis MM (). Genome Wide Association Study Reveals Genetically Distinct Phenotypic Subtypes of Age-related Macular Degeneration [Abstract]. American Society of Human Genetics 2011 Meeting.
  10. Amoaku W, Silvestri V, Akafo S, Lartey S, Bernstein P, Silvestri G, Hageman GS (). Clinical Phenotypes of Age-related Macular Degeneration (AMD) in Ghana [Abstract]. Ghana Biomedical Convention.
  11. Amoaku W, Silvestri V, Lartey S, Miller N, Nichols L, Bernstein P, Akafo S, Hageman G, Silvestri G (). The Vitreomacular interface in the Ghanaian African Population [Abstract]. Ghana Biomedical Convention.
  12. Hageman GS (). New Insights Into the Biology and Genetics of Age-related Macular Degeneration [Abstract]. 5th International Complement Therapeutics Conference.
  13. Newman AM, Gallo N, Hancox L, Miller N, Radeke C, Anderson D, Hageman GS, Johnson L, Radeke M (). Novel Gene Expression Signatures Associated with AMD and Its Risk Factors [Abstract]. The Association for Research in Vision and Ophthalmology.
  14. Smith T, Xu L, Pumariega N, Bearelly S, Blonska A, Sohrab M, Hageman GS (). A Scanning Laser Ophthalmoscopic Study of Reticular Pseudodrusen and Multilobular Geographic Atrophy [Abstract]. The Association for Research in Vision and Ophthalmology.
  15. Silveira AC, Morrison MA, Zacharaki F, Adams S, Arneberg TM, Sato H, Kotoula MG, Tsironi EE, Tsiloulis AN, Chatzoulis DZ, MIler JW, Kim IK, Hollis BW, Haider NB, Hageman GS, Chen R, Deangelis MM (). Network Analysis of Genome Wide Association Data and Candidate Gene Association Implicates a Novel Vitamin D/Calcium Pathway in the Pathogenesis of Neovascular Age-related Macular Degeneration [Abstract]. The Association for Research in Vision and Ophthalmology.
  16. Smith T, Hageman GS (). Is Primary Multifocal Geographic Atrophy in AMD a Form of Reticular Macular Disease? [Abstract]. 34th Annual Macula Society Meeting.
  17. Cherapanoff SC, Killingsworth M, Shen W, Guymer R, Hageman GS, Gillies M (). Ultrastructural Findings in Type II Macular Telangiectasia [Abstract]. Asia-ARVO.
  18. Gillies M, Shen W, Len A, Guyer R, Hageman GS, Fruttiger M (). Idiopathic Macular Telangiectasia Type 2-A Prototypic Muller Cell Defect? [Abstract].
  19. Hageman GS (). A New Era in Our Understanding of Age-related Macular Degeneration [Abstract]. Retina 2010, Dublin, Ireland.
  20. Jun G, Nicolaou M Morrison MA, Kim IK, Schaumberg DA, Kotoula MG, Tsironi EE, Zacharaki F, Hageman GS, Farrer LA, DeAngelis MM (). Gene-Gene Interaction between ROBO1 and RORA in Neovascular Age-related Macular Degeneration [Abstract]. The American Society of Human Genetics.
  21. Hageman GS (). Imflammation and Complement in Age-related Macular Degeneration [Abstract]. American Association of Ophthalmology.
  22. DeAngelis MM, Morrison MA, Silveira AC, Adams SM, Kim IK, Haider NB, Jelcick A, Hollis BW, Chen R, Hageman GS, Schaumberg DA (). Genetic Data Suggest a Novel Association Between the Vitamin D Pathway and the Development of Age-related Macular Degeneration [Abstract]. The American Society of Human Genetics.
  23. Hageman GS (). A New Era for Age-related Macular Degeneration: Biological and Theraputic Insights [Abstract]. XIVth International Symposium on Retinal Degeneration RD 2010.
  24. Hageman GS (). A New Era in Our Understanding of Age-related Macular Degeneration [Abstract]. 16th Retina International World Congress.
  25. Powner, MB, Gillies MC, Tretiach M, Scott A, Guymer RH, Hageman GS, Fruttiger M (). Glia Cells' Function in the Healthy and Diseased Retina [Abstract]. The Association for Research in Vision and Ophthalmology.
  26. Silveira AC, Morrison MA, Kim IK, Schaumberg DA, Hollis BW, Chen R, Hageman GS, DeAngelis MM (). Genetic Data suggest a Novel Association Between the Vitamin D Pathway and Neovascular Age-Related Macular Degeneration [Abstract]. The Association for Research in Vision and Ophthalmology.
  27. Jun G, Agams SM, Kim IK, MIller JW, Hageman GS, Kotoula MG, Tsironi EE, Farrer LA, DeAngelis MM (). Extended analysis in the 10q26 Region for Neovascular Age-related Macular Degeneration (AMD) [Abstract]. The Association for Research in Vision and Ophthalmology.
  28. Seyedahmadi BJ, Yonekawa Y, Morrison MA, Kim IK, Miller JW, Haider NB, Hageman GS, Farrer LA, Jun G, DeAngelis MM (). The Roundabout, Axon Guidance Receptor, Homolog 1 (ROBO1), a Potential Modifier and Therapeutic Target for Early and Intermediate Dry Age-Related Macular Degeneration [Abstract]. The Association for Research in Vision and Ophthalmology.
  29. Newman AM, Gallo N, Hancox L, Miller N, Radeke C, Anderson D, Hageman GS, Johnson L, Radeke M (). Novel Gene Expression Signatures Associated with AMD and Its Risk Factors [Abstract]. The Association for Research in Vision and Ophthalmology.
  30. Jackson JR, Hageman GS, Saggau DD, Barnes CH, Rothman RJ, Tarantola RM, Gehrs KM (). Response to Intravitreal Anti-VEGF Therapy in Individuals With Advanced Exudative Age-related Macular Degneration [Abstract]. The Association for Research in Vision and Ophthalmology.
  31. Brown EN, Hancox, LS, Miller NJ, Hageman JL, Pappas CM, Hutcheson DA, Morrison MA, Leppert MF, DeAngelis MM, Hageman GS (). Determination and Assessment of Extended Haplotypes Spanning the Chromosome 1q32 CFH-To-CFHR5 Locus [Abstract]. The Association for Research in Vision and Ophthalmology.
  32. Silvestri V, Megaw K, Moore E, McAvoy C, Hageman GS, Silvestri G (2009). Progression of retinal changes in membranoproliferative glomerulonephritis type II [Abstract]. ARVO.
  33. Kelly UL, Ding J, Hageman GS, Arshavsky V, Jiang H, Frank M, Rickman CB (2009). Heparan sulfate in human Bruch’s membrane/choroid tissue increases the rate of proteolytic cleavage of C3b by factors H and I [Abstract]. ARVO.
  34. Millen AE, Voland R, Wallace RB, Hageman GS, Klein ML, Sarto GE, Chappell RJ, Parekh N, Mares JA (2009). Relationships between vitamin D status and age-related macular degeneration (AMD) in the Carotenoids and Age-Related Eye Disease Study, an ancillary study of the Women’s Health Initiative Observational Study (WHIOS) [Abstract]. ARVO.
  35. Rao HV, Cai J, Afzal A, Grant M, Akin D, Dunn W, Kim J-S, Hageman GS, Boulton M (2009). A decline in autophagic efficiency is associated with AMD and chronic exposure to oxidative stress [Abstract]. ARVO.
  36. Hageman GS, Gehrs K, Allikmets R, Bok D, Johnson LV, Anderson DH (2008). A Role for Aberrant Complement Regulation in Age-related Macular Degeneration [Abstract]. ARVO.
  37. Kelly U, Mina E, Lin J, Hageman GS, Arshavsky V, Jiang H, Frank M, Rickman CB (2008). Investigation of the interactions between complement Factor H, C3b, and amyloid β [Abstract]. ARVO.
  38. Len CL, Hageman GS, Gillies MC (2008). Taking a quantitative mass spectroscopy based approach to identifying putative disease biomarkers of macular degeneration [Abstract]. ARVO.
  39. Laine M, Jarva H, Seitsonen S, Haapasalo K, Lehtinen MJ, Lindeman N, J228rvel228 I, Jokiranta TS, Hageman GS, Immonen I, Meri S (2007). Pathogenesis of age-related macular degeneration: Disrupted binding of complement factor H to C-reactive protein [Abstract]. Mol Immunol, 44, 202.
  40. Gold B, Hancox LS, Merriam JE, Bergeron J, Taiber AJ, Zernant J, Olsh AJ, Barile GR, Hardisty LI, Cramer K, Neel J, Smith RT, Borchardt JD, Hageman GS, Allikmets R, Dean M (2006). Alternative complement pathway genes strongly associate with age-related macular degeneration (AMD) [Abstract]. The American Society of Human Genetics, 56th Annual Meeting Abstracts, number 1733/A, 321.
  41. Strettoi E, Mazzoni F, Novelli E, Pignatelli V, Hageman GS (2006). Progressive changes in the morphology and survival of inner retinal cells in mice with photoreceptor degeneration: correlations to human retinits pigmentosa [Abstract]. ICER.
  42. Dean M, Gold B, Bergeron J, Allikmets R, Hageman GS (2005). Evolution and distribution of haplotypes in the complement Factor H (CFH) gene that predispose to age-related macular degeneration [Abstract]. ASHG.
  43. Strettoi E, Pignatelli V, Hageman GS (2005). Morphological abnormalities of bipolar cells in human retinitis pigmentosa [Abstract]. Neuroscience.
  44. Hageman GS (2005). RPE-extracellular matrix interactions in retinal degeneration [Abstract]. Invest Ophthalmol Vis Sci Suppl.
  45. Bonnet DM, Hageman GS, Sahel J, Hicks D (2005). Human glaucomatous retinal ganglion cells in vitro: intrinsic inability for neuritogenesis? [Abstract]. Invest Ophthalmol Vis Sci, 46, E-Abstract 168.
  46. Scheetz T, Braun A, Hageman G, Casavant TL, Sheffield VC, Soares MB, Stone EM (2005). Gene discovery in the human visual system [Abstract]. Invest Ophthalmol Vis Sci Suppl, 46, E-Abstract 3100.
  47. Lu Q, Hancox L, Russell SR, Stevenson R, Campos M, Pincheira R, Hernandez M, Araneda C, Meza P, Ormeno A, Poblete R, Hageman GS (2004). Comparison of apolipoprotein E genotypes in Rapanui ad Caucasian populations support a role for this gene in the susceptibility toward age-related macular degeneration [Abstract]. Invest Ophthalmol Vis Sci Suppl, 45, E-Abstract 1835.
  48. Mullins RF, Malone EA, Aptsiauri N, Lemke JH, Hageman GS (2004). Choriocapillaris degeneration in age-related maculopathy: Association with terminal complement complex deposition [Abstract]. Invest Ophthalmol Vis Sci Suppl, 45, E-Abstract 2288.
  49. Bok D, Hageman GS, Hu J, Hancox L, Wang Y (2004). Expression and functional analyses of toll-like receptors in human retinal pigment epithelial cells [Abstract]. Invest Ophthalmol Vis Sci Suppl, 45, E-Abstract 636.
  50. Luthert PJ, Amin SZ, Keonin J, Hageman GS (2003). Pathogenesis of sub-RPE deposits [Abstract]. Third International DOG Symposium, Baden-Baden, Germany.
  51. Hageman GS, Mullins RF, Keonin J, Kuehn M, Johnson LV, Anderson D, Luthert P, Chong V, Amin S (2003). Is AMD an Inflammatory Disease? [Abstract]. Third International DOG Symposium, Baden-Baden, Germany.
  52. Mullins RF, Kuehn MH, Aptsiauri N, Hageman GS (2003). Distribution of terminal complement complexes at the RPE-choriocapillaris interface in age-related macular degeneration [Abstract]. Invest Ophthalmol Vis Sci Suppl, 44, E-Abstract 4226.
  53. Hageman GS, Chong NH, Keonin J, Amin S, Klaver CW, Frennesson CI, Russell SR, Luthert PJ, Mullins RF, Kuehn MH (2002). Topographical differences in the structure and composition of Bruch’s Membrane may help to explain the predilection of the macula for degeneration in age-related macular degeneration [Abstract]. Invest Ophthalmol Vis Sci Suppl, 43, S1988.
  54. Hageman GS (2001). Toward the characterization of pathways and genes involved in the etiology of age-related macular degeneration [Abstract]. Schepen’s International Society Proc.
  55. Clark AF, Jacobson N, Shepard AR, Kwon Y, Hageman G, Zhang X, McLaughlin M, Yorio T, Sheffield VC, Stone EM (2001). Expression of myocilin in human and rabbit aqueous humor [Abstract]. Invest Ophthalmol Vis Sci Suppl, 42, S834.
  56. Sebag JS, Hageman GS (2001). Interface biology and neovascularization [Abstract]. Schepen’s International Society Proc.
  57. Lotery AJ, Sheffield V, Hageman GS, Affatigato L, Haines H, Stone EM (2000). What can dominant macular dystrophies teach us about age-related macular degeneration? [Abstract]. Proc Int Soc Eye Res, 14, S168.
  58. Kuehn MH, Hageman GS (2000). IPM 150 and IPM 200 are members of a novel family of proteoglycans [Abstract]. Invest Ophthalmol Vis Sci Suppl, 41, 3154.
  59. Sheffield VC, Andrews M, Shepard A, Jacobson N, Searby C, Nishimura D, Kwon Y, Davidson B, Hageman GS, Alward WLM, Clarke AF, Stone EM (2000). Mutations in the glaucoma gene, MYOC, result in normal synthesis but abnormal secretion of the myocilin protein [Abstract]. Am Soc Hum Gen.
  60. Hageman GS, Mullins RF (2000). Participation of immune-mediated events in drusen biogenesis and age-related macular degeneration [Abstract]. IRPA 2000.
  61. Hageman GS, Hancox L, Mullins RF (2000). Toward the characterization of pathways involved in the etiology of age-related macular degeneration: A strategy based upon the use of human donor eyes, proteomics, and gene array analyses [Abstract]. Alcon Ocular Genomics and Proteomics Symposium.
  62. Mullins RF, Hancox LS, Hageman GS (2000). The composition and biosynthesis of drusen: Immunohistochemical, molecular and proteomic analyses [Abstract]. Proc Int Soc Eye Res, 14, S157.
  63. Hageman GS (2000). The role of RPE and immune-mediated events in age-related maculopathy [Abstract]. EU meeting on RPE.
  64. Hageman GS (2000). Toward the Characterization of Pathways Involved in the Etiology of Age-Related Macular Degeneration [Abstract]. Ciba Visudyne Launch Symposium, Stockholm, Sweden.
  65. Swiderski RE, Fingert JH, Ross JL, Alward WLM, Hageman GS, Stone EM, Sheffield VC (2000). Localization of MYOC (GLC1A) transcripts in the human eye and optic nerve by in situ hybridization [Abstract]. Central States EM Society.
  66. Mullins RF, Speth CR, Hageman GS (2000). Composition and origin of extracellular deposits in Bruch's membrane of human donors with age-related macular degeneration [Abstract]. Connective Tissue Res.
  67. Hageman GS (2000). Pathology of the aging macula [Abstract]. 30th Cambridge Ophthalmological Symposium.
  68. Mullins RF, Aptsiauri N, Hageman GS (2000). Dendritic cells and proteins involved in immune-mediated processes are associated with drusen and may play a central role in drusen biogenesis [Abstract]. Invest Ophthalmol Vis Sci Suppl, 41, 122.
  69. Frennesson C, Weingeist D, Nienhaus H, Mullins R, Hageman G (2000). Vitronectin distribution in the choroidal stroma and Bruch’s membrane as related to age and age-related macular degeneration [Abstract]. Invest Ophthalmol Vis Sci Suppl, 41, 120.
  70. Russell SR, Gupta RR, Folk JC, Mullins RF, Hageman GS (2000). Comparison of color drusen images to fluorescein angiographic hyperfluorescence lesions in early adult onset (basal laminar) drusen [Abstract]. Invest Ophthalmol Vis Sci Suppl, 41, 875.
  71. Chakravarthy U, Patton WP, Hageman GS (2000). Molecular pathways mediating RPE damage on exposure to constituents of cigarette smoke [Abstract]. Proc Int Soc Eye Res, 14, S158.
  72. Anderson DH, Ozaki S, Nealon M, Neitz J, Mullins RF, Hageman GS, Johnson LV (2000). Local cellular sources of apolipopretein E in the human retina and retinal pigmented epithelium: Implications for drusen formation [Abstract]. Proc Int Soc Eye Res, 14, S158.
  73. Hageman GS, Mullins RF (2000). Immune-mediated events at the RPE-Bruch's membrane interface in aging and age-related macular degeneration immunohistochemical, molecular and proteomic analyses [Abstract]. Deutschen Ophthalmologischen Gesellschaft.
  74. Hageman GS, Mullins RF (1999). The composition and biogenesis of ocular drusen [Abstract]. IX International Symposium on ICG Angiography. Baden-Baden, Germany.
  75. Hageman GS (1999). Recent Insights into the Pathogenesis of Age-Related Macular Degeneration [Abstract]. Iowa Microscopy Society Proceedings.
  76. Stone EM, Lotery AJ, Munier FL, Guymer RH, Hageman GS, Heon E (1999). A single EFEMP1 mutation is associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy [Abstract]. Western Eye Research Conference, Taos, New Mexico.
  77. Yarovinsky TO, Rickman DW, Hageman GS, Rickman CB (1999). Identification and characterization of the protein tyrosine phosphatase, PRL-1, in human and monkey cone photoreceptors [Abstract]. Soc Neurosci Abstracts, 25, 139.
  78. Anderson DH, Johnson LV, Schneider BL, Nealson M, Mullins RF, Hageman GS (1999). Age-related maculopathy: A model of drusen biogenesis [Abstract]. Invest Ophthalmol Vis Sci Suppl, 40, 4863.
  79. Hageman GS, Anderson DH, Mullins RF (1999). An integrated hypothesis for the role of RPE cell death and immune-mediated processes in the etiologu of age-related macular degeneration [Abstract]. Western Eye Research Conference, Taos, New Mexico.
  80. Shappel W, Haynes G, Mark AL, Stone EM, Hageman GS (1999). Retinal outer segment degeneration in Kolesky rats [Abstract]. Invest Ophthalmol Vis Sci Suppl, 40, 5135.
  81. Hageman GS, Mullins R, Davisson M, Hawes N, Chang B, Nishina P, Heckenlively J (1999). Evaluation of the rd6/rd6 mouse as a model for drusen biogenesis [Abstract]. The Jackson Laboratory Retinal Degenerations Symposium and Workshop, Bar Harbor, Maine.
  82. Mullins RF, Hageman GS (1999). Assessment of the role of choroidal dendritic cells in drusen biogenesis [Abstract]. Western Eye Research Conference, Taos, New Mexico.
  83. Hageman GS, Russell SR (1999). Use of chondroitinase during vitrectomy elicits vitrreous dinsinertion in monkeys and brain-dead humans [Abstract]. The Schepens International Society Meeting.
  84. Ozaki S, Johnson LV, Hageman GS, Mullins RF, Anderson DH (1999). Relative quantitation of gene expression by the retina and RPE of two drusen-associated molecules [Abstract]. Invest Ophthalmol Vis Sci Suppl, 40, 4850.
  85. Swiderski RE, Fingert JH, Ross JL, Alward WLM, Hageman GS, Stone EM, Sheffield V (1999). Localization of MYOC (GLC1A) transcripts in human eye and optic nerve by in situ hybridization [Abstract]. Am J Hum Genetics, 65, 2156.
  86. Hageman GS, Mullins RF, Kuehn MH, Stone EM (1998). Characterization of extracellular deposits associated with AMD [Abstract]. VIII International Symposium on Retinal Degeneration, Schluchsee, Germany.
  87. Kuehn MH, Hageman GS (1998). Analyses of differential gene expression in age-related macular degeneration [Abstract]. Pathogenesis and Treatment of Age-Related Macular Degeneration, Johns Hopkins University.
  88. Hageman GS, Mullins RF (1998). The composition and origin of ocular drusen and basal laminar deposit [Abstract]. Pathogenesis and Treatment of Age-Related Macular Degeneration, Johns Hopkins University.
  89. Hageman GS (1998). Gene expression in age-related macular degeneration [Abstract]. The Ruth and Milton Steinbach Fund Meeting, Rockefeller University, New York.
  90. Mullins RF, Speth CR, Schneider BL, Hageman GS (1998). Compositional and ultrastructural analyses suggest a role for a cell-mediated process in drusen biogenesis [Abstract]. VIII International Symposium on Retinal Degenerations, Exp Eye Res Suppl, 67, S101.
  91. Johnson LV, Staples MK, Avery RL, Hageman GS, Anderson DH (1998). Acute phase reactants in age-related macular degeneration [Abstract]. Invest Ophthalmol Vis Sci Suppl, 39, 383.
  92. Chang B, Hawes NL, Nusinowitz S, Bronson RT, Nishina PM, Smith RS, Hageman GS, Davisson MT, Roderick TH, Heckenlively JR (1998). Four new mouse models of retinal degeneration [Abstract]. VIII International Symposium on Retinal Degeneration, Germany.
  93. Anderson DH, Hageman GS, Mullins RF, Neitz M, Neitz J, Wu W, Nealon M, De Los Rios M, Johnson LV (1998). Local cellular sources of drusen-associated molecules [Abstract]. Invest Ophthalmol Vis Sci Suppl, 39, 369.
  94. Hodgetts A, Hussain AA, Starita C, Hageman GS, Marshall J (1998). Morphological and biochemical factors regulating fluid transport through Bruch’s membrane and their implications for the ageing process [Abstract]. Exp Eye Res Suppl, 67.
  95. Hodgetts A, Hussain AA, Hageman GS, Marshall J (1998). Effect of enzymatic modulation on the hydrodynamics of ageing human Bruch’s membrane [Abstract]. Invest Ophthalmol Vis Sci Suppl, 39, 369.
  96. Hageman GS (1997). Alterations in Bruch’s membrane: a favorite site for matrix diseases [Abstract]. Zimmerman Symposium, Am Acad Ophthalmol, San Francisco.
  97. Hageman GS (1997). Identification of molecular candidates for AMD: a multidisiplinary approach [Abstract]. Second International Symposium on ARMD. Glasgow, Scotland.
  98. Hageman GS, Mullins RF (1997). Observations on the ultrastructure and development of macular extracellular matrix abnormalities [Abstract]. International E. U. Meeting on the Genetics of Macular Degeneration. Amsterdam, Netherlands.
  99. Kuehn MH, Stone EM, Hageman GS (1997). Molecular analyses of IPM 150, a photoreceptor cell-specific proteoglycan [Abstract]. Invest Ophthalmol Vis Sci Suppl, 38, 599.
  100. Bowes Rickman C, Hageman GS (1997). Molecular Analysis of the Primate Fovea [Abstract]. Soc Neurosci Abstracts, 23, 707.15.
  101. Warner RB, Thompsen J, Kuehn MH, Franklin AF, Hageman GS (1997). Identification and characterization of differentially-expressed mRNAs by RPE cells from donors with age-related macular degeneration [Abstract]. AOA Forum.
  102. Franklin AF, Kuehn MH, Warner RB, Thompsen J, Russell SR, Bowes Rickman C, Hageman GS (1997). Evaluation of differentially-expressed RPE gene transcripts as candidates for age-related macular degeneration [Abstract]. Invest Ophthalmol Vis Sci Suppl, 38, 352.
  103. Mullins RF, Schneider BL, Russell SR, Hageman GS (1997). Drusen possess unique glycoconjugate cores [Abstract]. Invest Ophthalmol Vis Sci Suppl, 38, 354.
  104. Felbor U, Gehrig A, Koehler M, Schmid M, Kelsell R, Hunt DM, Kuehn M, Hageman GS, Maumenee-Husseis IE, Weber BHF (1997). Mapping, genomic organization and mutational analyses of a novel interphotoreceptor matrix gene (IPM150): a candidate for 6q-linked maculopathies [Abstract]. Am J Human Genetics Suppl, A333, 1947.
  105. Guymer RH, Hageman GS, Bird AC (1997). Choroidal endothelial cell processes into Bruch's membrane [Abstract]. Invest Ophthlamol Vis Sci Suppl, 38, 353.
  106. Hageman GS (1996). Analyses of the molecular constituents of age-related macular deposits [Abstract]. VII International Symposium on Retinal Degenerations, Sendai, Japan.
  107. Heckenlively JR, Hageman GS, Hawes N, Cheng B, Erway L, Roderick TH, Davisson MT (1996). Mouse models of hereditary retinal degeneration [Abstract]. VII International Symposium on Retinal Degenerations, Sendai, Japan.
  108. Hageman GS, Russell SR (1996). Chondroitinase-assisted vitrectomy [Abstract]. XII International Congress of Eye Research, Yokohoma, Japan, Exp Eye Res Suppl, 63, S.7.
  109. Hageman GS, Mullins RF, Johnson LV, Anderson DH, Schneider BL (1996). Analyses of the molecular constituents of age-related extracellular deposits [Abstract]. The Bath Macular Workshop, Bath, England.
  110. Hageman GS, Russell SR (1996). Retinal histology following mechanically-induced posterior vitreous detachments in primates [Abstract]. Suncoast Retina Research Forum, Sarasota, Florida.
  111. Russell SR, Kincaid MC, Hageman GS (1996). Pathological consequences of mechanically-induced posterior vitreous detachment [Abstract]. Invest Ophthalmol Vis Sci Suppl, 37, 497.
  112. Nakhoul NL, Romero MF, Waheed A, Davis BA, Mullins R, Hageman G, Sly WS, Boron WF (1996). Processing and functional expression of carbonic anhydrase isoforms in Xenopus laevis oocytes [Abstract]. FASEB J Exp Biol, 96, A88.
  113. Hageman GS, Mullins RF, Johnson LV, Anderson DH (1996). Cell biology of AMD: Analyses of age-related extracellular deposits [Abstract]. Invest Ophthalmol Vis Sci Suppl, 37, 450.
  114. Chang B, Hageman GS, Heckenlively JR, Hawes NL, Peng C, Roderick TH, Davisson MT (1996). A mouse model for retinitis albescens: A new pathologic finding for retinal white dots [Abstract]. Invest Ophthalmol Vis Sci Suppl, 37, 505.
  115. Hageman GS, Russell SR (May 12-13, 1995). Use of chondroitinase during vitrectomy elicits complete vitreous disinsertion [Abstract]. 1995 Suncoast Retina Research Forum, Sarasota, Florida.
  116. Mullins RF, Hageman GS, Anderson DH, Johnson LV (1995). Molecular composition of drusen: Histochemical and enzymatic characterization of glycoconjugates [Abstract]. Invest Ophthalmol Vis Sci Suppl, 36, 432.
  117. Meredith TA, Abdallah C, Aguilar HE, Chanping L, Hageman GS (1995). Toxicity of intravitreal ceftazidime and vancomycin [Abstract]. Invest Ophthalmol Vis Sci Suppl, 36, 789.
  118. Hageman GS, Mullins RF, Clark WG, Johnson LV, Anderson DH (1995). Drusen share molecular constituents common to atherosclerotic, elastotic and amyloid deposits [Abstract]. Invest Ophthalmol Vis Sci Suppl, 36, 432.
  119. Anderson DH, Johnson LV, Hageman GS (1995). Vitronectin receptor (VnR) is expressed on the apical surfaces of photoreceptor and RPE cells [Abstract]. Invest Ophthalmol Vis Sci Suppl, 36, 512.
  120. Schneider GP, Korn SP, Niesman MR, Hageman GS (1995). Vitreous hyalocytes and synoviocytes exhibit common phenotypic features [Abstract]. Invest Ophthalmol Vis Sci Suppl, 36, 750.
  121. Peng C, Hageman GS, Chang B, Heckenlively JR (1995). Electroretinographic abnormalities in rd5 heterozygous mice; comparison to homozygous and normal controls [Abstract]. Invest Ophthalmol Vis Sci Suppl, 36, 926.
  122. Niesman MR, Russell SR, Hageman GS (1995). Secretion of cytokines and growth factors by cultured human hyalocytes and epiretinal membrane explants [Abstract]. Invest Ophthalmol Vis Sci Suppl, 36, 205.
  123. Abdalla C, Meredith TA, Aguilar HE, Chanping L, Hageman GS (1995). Abdalla, C., T. A. Meredith, H. E. Aguilar, L. Chanping and G. S. Hageman [Abstract]. Invest Ophthalmol Vis Sci, 36, 1019.
  124. Kuehn MH, Hageman GS (1995). Characterization of a cDNA encoding IPM 150, a novel human interphotoreceptor matrix chondroitin 6-sulfate proteoglycan [Abstract]. Invest Ophthalmol Vis Sci Suppl, 36, 510.
  125. Bowes Rickman C, Hageman GS (1995). Identification of primate fovea-specific mRNAS [Abstract]. Invest Ophthalmol Vis Sci Suppl, 36, 621.
  126. Sires BS, Holds JB, Archer CR, Kincaid MC, Hageman GS (1994). Histological and radiological analyses of hydroxyapatite orbital implants in rabbits [Abstract]. Invest Ophthalmol Vis Sci Suppl, 35, 1444.
  127. Erway LC, Hageman GS, Heckenlively JR, Chang B, Peng C, Hawes NL, Roderick TH (1994). Hearing loss in the rd5 mutant mouse, a model for Usher's Type I [Abstract]. Amer Acad Otolaryngol.
  128. Hageman GS, Russell SR (1994). Chondroitinase-mediated disinsertion of the primate vitreous body [Abstract]. Invest Ophthalmol Vis Sci Suppl, 35, 1260.
  129. Russell SR, Hageman GS (1993). Enzymatic disinsertion of the vitreous body [Abstract]. Vitreous Society Annual Meeting, St. Thomas, U.S. Virgin Islands.
  130. Lazarus HS, Fakrat S, Hageman GS, Hackett SF, Campochiaro PA (1993). Hyalocyte-conditioned medium modulates RPE migration and proliferation [Abstract]. Invest Ophthalmol Vis Sci Suppl, 34, 1018.
  131. Russell SR, Hageman GS (1993). Enzymatic disinsertion of the vitreous body [Abstract]. New Dimensions in Retina Symposium, Chicago, Illinois.
  132. Kuehn MH, Mullins RF, Hageman GS (1993). Retinal interphotoreceptor matrix proteoglycan core protein sequences are unique and highly conserved [Abstract]. Invest Ophthalmol Vis Sci Suppl, 34, 1201.
  133. Korn SP, Kuehn MH, Schneider BL, Lazarus HS, Hageman GS (1993). Biochemical characterization of glycoproteins bound by a hyalocyte-specific antibody [Abstract]. Invest Ophthalmol Vis Sci Suppl, 34, 1201.
  134. Rotramel JR, Kirchoff-Rempe MA, Hageman GS (1992). Identification of core proteins of primate interphotoreceptor matrix chondroitin sulfate proteoglycans [Abstract]. St. Louis University School of Medicine AOA Student Research Forum.
  135. Korte GE, Marko M, Hageman GS (1992). High voltage electron microscopy of subretinal scar formation [Abstract]. Proc Electron Micros Soc Amer, 33.
  136. Rotramel JR, Kirchoff-Rempe MA, Hageman GS (1992). Identification of core proteins from primate interphotoreceptor matrix chondroitin sulfate proteoglycans [Abstract]. Invest.Ophthalmol Vis Sci Suppl, 33, 815.
  137. Kuehn MH, Hageman GS (1992). Identification of a cDNA clone encoding for an interphotoreceptor matrix proteoglycan [Abstract]. Invest Ophthalmol Vis Sci Suppl, 33, 814.
  138. Hageman GS, Russell SR (1992). Enzymatic disinsertion of the primate vitreous body [Abstract]. Tenth International Congress of Eye Research, Exp Eye Res Suppl, 55, 216.
  139. Hageman GS, Lazarus HS (1992). An altered composition of rod photoreceptor-associated interphotoreceptor matrix is associated with macular degeneration [Abstract]. Invest Ophthalmol Vis Sci Suppl, 33, 803.
  140. Hageman GS, Kirchoff-Rempe MA, Rotramel JR, Kuehn MH (1992). Molecular and compositional characterization of interphotoreceptor matrix proteoglycans [Abstract]. Tenth International Congress of Exp Eye Res Suppl, 55, 33.
  141. Hageman GS, Lazarus HS (1992). Compositional changes in human interphotoreceptor matrix proteoglycans associated with macular drusen [Abstract]. Tenth International Congress of Eye Research, Exp Eye Res Suppl, 55, 237.
  142. Lazarus HS, Russell SR, Zahn S, Hageman GS (1992). Histochemical evidence for vitreous hyalocytes as components of pathologic vitreous membranes [Abstract]. Invest Ophthalmol Vis Sci Suppl, 33, 858.
  143. Russell SR, Hageman GS (1992). Role of insoluble interphotoreceptor matrix in eliciting vitreous cellular proliferations in the human [Abstract]. Tenth International Congress of Eye Research, Exp Eye Res Suppl, 55, 237.
  144. Hageman GS, Marmor MF, Johnson LV (1992). Do interphotoreceptor matrix glycoconjugates participate in retinal adhesion? [Abstract]. Tenth International Congress of Eye Research, Exp Eye Res Suppl, 55, 225.
  145. Kim CK, Kirchoff-Rempe MA, Hageman GS (1992). Interspecies biochemical heterogeneity of cone matrix sheath-associated proteoglycans [Abstract]. St. Louis University School of Medicine AOA Student Research Forum.
  146. Mantych G, Hageman GS, Anderson K, Devaskar S (1991). Immunocytochemical localization of a family of glucose transporters in the developing human eye [Abstract]. Pediatric Res, 29, 1156.
  147. Pfeffer BA, Kirchoff-Rempe M, Guerin CJ, Matsumoto B, Anderson DH, Hageman GS (1991). RPE contribution to primate interphotoreceptor matrix, assessed by analysis of proteins biosynthetically labelled in situ and in vitro [Abstract]. Invest Ophthalmol Vis Sci Suppl, 32, 1217.
  148. Ni M, Hageman GS, Moore TL, Osborn TG, Bloom JN (1991). Antiocular antibodies in JRA and non-JRA uveitis patients [Abstract]. Invest Ophthalmol Vis Sci Suppl, 32, 935.
  149. Kratz-Owens K, Hageman GS, Schanzlin DJ (1991). An in vivo technique for monitoring keratocyte migration following lamellar keratoplasty [Abstract]. Invest Ophthalmol Vis Sci Suppl, 32, 1002.
  150. Kirchoff-Rempe MA, Hageman GS, Lewis GP, Fisher SK, Anderson K, Anderson DH (1991). Association of immunoreactive basic fibroblast growth factor with the insoluble interphotoreceptor matrix [Abstract]. Invest Ophthalmol Vis Sci Suppl, 32, 1216.
  151. Lazarus HS, Kirchoff-Rempe MA, Hageman GS (1991). Characterization of apically-distributed interphotoreceptor glycoconjugates in the primate retina [Abstract]. Invest Ophthalmol Vis Sci Suppl, 32, 1216.
  152. Anderson DH, Hageman GS, Guerin CJ, Flanders KC (1991). Immunolocalization of transforming growth factor (TGF)-ß1, TGF-ß2, and TGF-ß3 in mammalian retinas [Abstract]. Invest Ophthalmol Vis Sci Suppl, 32, 754.
  153. Kim CK, Kirchoff-Rempe MA, Anderson K, Hageman GS (1991). Interspecies biochemical heterogeneity of cone matrix sheath-associated proteoglycans [Abstract]. Invest Ophthalmol Vis Sci Suppl, 32, 1217.
  154. Russell SR, Hageman GS (1991). Insoluble interphotoreceptor matrix is present in human vitreous following rhegmatogenous retinal detachment [Abstract]. Invest Ophthalmol Vis Sci Suppl, 32, 878.
  155. Marmor MF, Hageman GS, Yao X-Y (1991). Retinal adhesiveness and interphotoreceptor matrix morphology in a human eye [Abstract]. Invest Ophthalmol Vis Sci Suppl, 32, 667.
  156. Kratz-Owens K, Schanzlin DJ, Hageman GS (1990). Identification and characterization of a posterior corneal filamentous network [Abstract]. Invest Ophthalmol Vis Sci Suppl, 31, 31.
  157. Lazarus HS, Johnson LV, Hageman GS (1990). Xyloside-induced perturbation of cone matrix sheaths [Abstract]. Proc Int Soc Eye Res, 6, 179.
  158. Russell SR, Hageman GS (1990). Does insoluble interphotoreceptor matrix elicit epiretinal membrane formation? [Abstract]. Vitreous Society Annual Meeting, Hawaii.
  159. Kirchoff MA, Anderson DH, Lewis GP, Fisher SK, Hageman GS (1990). Sequestration of basic fibroblast growth factor in the retinal interphotoreceptor matrix [Abstract]. J Cell Biol, 111, 223a.
  160. Kirchoff MA, Anderson K, Johnson LV, Hageman GS (1990). Composition and distribution of insoluble interphotoreceptor matrix constituents [Abstract]. Invest Ophthalmol Vis Sci Suppl, 31, 153.
  161. Besharse JC, Hageman GS (1990). Incorporation of fluorescent lipid probes into rod photoreceptor distal tips suggests formation of transient disc-plasma membrane continuities associated with disc shedding [Abstract]. Invest Ophthalmol Vis Sci Suppl, 31, 5.
  162. Yao X-Y, Hageman GS, Marmor MF (1990). Recovery of retinal adhesiveness after enzymatic degradation of the interphotoreceptor matrix [Abstract]. Invest Ophthalmol Vis Sci Suppl, 31, 5.
  163. Mantych G, Hageman GS, Anderson K, Devaskar S (1990). Immunocytochemical localization of glucose transporters in the developing human eye [Abstract]. Clinical Res, 38, 804a.
  164. Dorey CK, Delori FC, Curran S, Hageman GS (1990). Emission spectra of cone lipofuscin granules in situ [Abstract]. Invest Ophthalmol Vis Sci Suppl, 31, 472.
  165. Lazarus HS, Anderson K, Kyle JW, Berkenmeir EH, Sly WS, Hageman GS (1990). Characterization and fate of the interphotoreceptor matrix in ß-glucuronidase-deficient mice [Abstract]. Invest Ophthalmol Vis Sci Suppl, 31, 73.
  166. Kita M, Negi A, Yao X-Y, Hageman GS, Marmor MF (1990). Experimental studies on retinal adhesion [Abstract]. Proc Int Soc Eye Res, 6, 179.
  167. Hageman GS, Besharse JC (1990). "Cytoplasmic caps" at the apices of mammalian photoreceptors exhibit a circadian rhythm that peaks at night [Abstract]. Invest Ophthalmol Vis Sci Suppl, 31, 5.
  168. Schanzlin DJ, Kratz-Owens K, Hageman GS (1990). Keratocyte subpopulation as revealed by lectin-binding [Abstract]. Invest Ophthalmol Vis Sci Suppl, 31, 32.
  169. Hageman GS, Kirchoff MA, Anderson DH (1990). Biochemical characterization and distribution of retinal interphotoreceptor matrix glycoconjugates [Abstract]. Glycoconjugate J, 7, 512.
  170. Russell SR, Hageman GS (1990). Intravitreal injection of insoluble interphotoreceptor matrix constituents induces epiretinal membrane formation in monkeys [Abstract]. Invest Ophthalmol Vis Sci Suppl, 31, 197.
  171. Russell SR, Hageman GS (1989). Lectin-based characterization of glycoconjugates in chondroitin sulfate-induced epiretinal and intravitreal membranes [Abstract]. Invest Ophthalmol Vis Sci Suppl, 30, 394.
  172. Rana MW, Hageman GS (1989). Scanning electron microscopic examination of monkey photoreceptor calycal processes and interphotoreceptor matrix [Abstract]. Anat Rec, 223, 93A.
  173. Galanis JC, Hageman GS (1989). Localization of lectin-binding glycoconjugates in the primate trabecular meshwork [Abstract]. Invest Ophthalmol Vis Sci Suppl, 30, 355.
  174. Pratt DV, Johnson LV, Lean J, Hageman GS (1989). Immunologically detected changes of glial and RPE cells in long term retinal detachment [Abstract]. Invest Ophthalmol Vis Sci Suppl, 30, 207.
  175. Lazarus HS, Hageman GS (1989). Xyloside-induced perturbation of "cone matrix sheath" structure and composition in vivo [Abstract]. Invest Ophthalmol Vis Sci Suppl, 30, 490.
  176. Anderson K, Hageman GS, Blanks JC, Spee C (1989). Developmental expression of human cone matrix sheath-specific molecules [Abstract]. Invest Ophthalmol Vis Sci Suppl, 30, 490.
  177. Yao XY, Marmor MF, Hageman GS (1989). Interphotoreceptor matrix plays an important role in retinal adhesiveness [Abstract]. Invest Ophthalmol Vis Sci Suppl, 30, 240.
  178. Blanks JC, Anderson K, Spee C, Hageman GS (1989). Developmental expression of human cone matrix sheath-specific molecules [Abstract]. J Comp Neurol Suppl, 15, 494.
  179. Hageman GS, Hewitt AT, Johnson LV, Kirchoff M (1989). Characterization of retinal cone photoreceptor-associated glycoconjugates [Abstract]. Xth International Symposium on Glycoconjugates, Israel.
  180. Sater GR, Hageman GS (1989). Construction of a porcine retinal cDNA library and selection of clones recognized by cone matrix sheath-specific antibodies [Abstract]. Invest Ophthalmol Vis Sci Suppl, 30, 490.
  181. Hageman GS, Hewitt AT, Kirchoff M, Johnson LV (1989). Selective extraction and characterization of cone matrix sheath-specific molecules [Abstract]. Invest Ophthalmol Vis Sci Suppl, 30, 489.
  182. Johnson LV, Hageman GS (1989). Characterization of cone matrix sheath substructure [Abstract]. Invest Ophthalmol Vis Sci Suppl, 30, 490.
  183. Hageman GS, Johnson LV (1988). The cone matrix sheath: Structural, compositional and functional analyses [Abstract]. Invest.Ophthalmol Vis Sci Suppl, 29, 108.
  184. Pratt DV, Korte GE, Johnson LV, Hageman GS (1988). Altered expression of a Müller cell-specific antigen in sodium-iodate induced retinopathy [Abstract]. Eighth International Congress of Eye Research, Proc Int Soc Eye Res, 5, 124.
  185. Kirk JD, Hageman GS, Anderson K, Kash RL, Schanzlin DJ (1988). Distribution of lectin-binding glycoconjugates in the cornea and sclera [Abstract]. Invest Ophthalmol Vis Sci Suppl, 29, 50.
  186. Hageman GS, Johnson LV (1988). Characterization of cone photoreceptor matrix sheath structure, composition and function [Abstract]. Eighth International Congress of Eye Research, Proc Int Soc Eye Res, 5, 25.
  187. Pratt DV, Hageman GS, Johnson LV (1988). Immunological characterization of an antigen expressed by Müller cell apical microvilli [Abstract]. Invest Ophthalmol Vis Sci Suppl, 29, 244.
  188. Johnson LV, Garner JA, Hageman GS (1988). Immunologic detection of retinal synapse-associated molecules [Abstract]. Invest Ophthalmol Vis Sci Suppl, 29, 348.
  189. Johnson LV, Blanks JC, Hageman GS (1988). Fate of cone-associated interphotoreceptor matrix during retinal degenerations [Abstract]. Fifth International Retinitis Pigmentosa Congress.
  190. Pratt DV, Johnson LV, Hageman GS (1987). Polarized distribution of a Müller cell-specific antigen [Abstract]. Invest Ophthalmol Vis Sci Suppl, 28, 258.
  191. Hageman GS, Johnson LV (1987). Molecular and structural organization of the extracellular matrix associated with primate cone photoreceptors [Abstract]. J Cell Biol, 105, 1656a.
  192. Hageman GS, Johnson LV (1987). Chondroitin 6-sulfate glycosaminoglycan is a major constituent of primate cone photoreceptor matrix sheaths [Abstract]. Invest Ophthalmol Vis Sci Suppl, 28, 254.
  193. Pratt DV, Hageman GS, Johnson LV (1987). Asymmetrical distribution of a microvillous protein in retinal glial cells [Abstract]. USC Student Research Forum.
  194. Johnson LV, Hageman GS (1987). Biochemical characterization of molecules bound by cone-specific monoclonal antibody CSA-1 [Abstract]. Invest Ophthalmol Vis Sci Suppl, 28, 341.
  195. Blanks JC, Hageman GS, Johnson LV (1987). Stage specific appearance of peanut agglutinin-binding cells in the outer nuclear layer of rd mice [Abstract]. Invest Ophthalmol Vis Sci Suppl, 28, 140.
  196. Basinger SF, Hageman GS, Robles LJ (1986). Wheat germ agglutinin identifies a subclass of presumptive bipolar cells in Rana pipiens [Abstract]. Invest Ophthalmol Vis Sci Suppl, 27, 229.
  197. Blanks JC, Hageman GS, Johnson LV (1986). Further evidence for the existence of mammalian cone sheaths: Ultrastructural localization of peanut-agglutinin-binding glycoconjugates [Abstract]. Seventh International Congress of Eye Research, Proc Int Soc Eye Res, 4, 21.
  198. Blanks JC, Johnson LV, Hageman GS (1986). Lectin binding to glycoconjugates of vertebrate photoreceptor cells [Abstract]. Seventh International Congress of Eye Research, Proc Int Soc Eye Res, 4, 159.
  199. Hageman GS, Schmidt SY (1986). Taurine-deficient pigmented and albino rats: Early retinal abnormalities and differential rates of photoreceptor degeneration [Abstract]. Sendai Symposium on Retinal Degeneration, Japan.
  200. Johnson LV, Hageman GS (1986). Characterization of the determinant recognized by cone-specific monoclonal antibody CSA-1 [Abstract]. Seventh International Congress of Eye Research, Proc Int Soc Eye Res, Exp Eye Res, 4, 22.
  201. Schmidt SY, Hageman GS, Hayes KC, Claycomb RC, Sandberg M (1986). Taurine deficiency results in earlier onset of photoreceptor degeneration in albino than in pigmented rats [Abstract]. Invest Ophthalmol Vis Sci Suppl, 27, 57.
  202. Blanks JC, Hageman GS, Johnson LV (1986). Further evidence for the existence of mammalian cone sheaths: Ultrastructural localization of peanut agglutinin-binding glycoconjugates [Abstract]. Seventh International Congress of Eye Research, Proc Int Soc Eye Res, Exp Eye Res, 4, 21.
  203. Hageman GS, Johnson LV (1986). Distribution of IgA and IgG within the interphotoreceptor matrix: Selective association with cone photoreceptors [Abstract]. Invest Ophthalmol Vis Sci Suppl, 27, 239.
  204. Blanks JC, Hageman GS, Johnson LV (1986). Stage-specific appearance of peanut agglutinin-binding cells in the outer nuclear layer of rd mice [Abstract]. Sendai Symposium on Retinal Degeneration, Japan.
  205. Johnson LV, Hageman GS (1986). Specific binding of a monoclonal antibody (CSA-1) to cone photoreceptor outer segments [Abstract]. Invest Ophthalmol Vis Sci Suppl, 27, 234.
  206. Hageman GS, Johnson LV (1986). Further characterization of cone-associated interphotoreceptor matrix domains [Abstract]. Seventh International Congress of Eye Research, Proc Int Soc Eye Res, 4, 22.31.
  207. Schmidt SY, Hageman GS (1985). Taurine in the photoreceptors: Effect of taurine deficiency [Abstract]. "Pineal-Retinal Relationships" Symposium sponsored by the National Eye Institute.
  208. Hageman GS, Johnson LV (1985). Novel ultrastructural observations on monkey cone photoreceptors [Abstract]. Invest Ophthalmol Vis Sci Suppl, 26, 247.
  209. Hageman GS, Hayes KC, Claycomb RC, Schmidt SY (1985). Effects of taurine deficiency in cat and rat retinas: Early ultrastructural observations [Abstract]. J Cell Biol, 101, 221a.
  210. Johnson LV, Hageman GS (1985). Further elucidation of peanut agglutinin-binding in porcine retinae [Abstract]. Invest Ophthalmol Vis Sci Suppl, 26, 336.
  211. Hageman GS, Johnson LV (1984). Lectin-binding glycoproteins in the vertebrate vitreous body and inner limiting membrane: Tissue localization and biochemical characterization [Abstract]. J Cell Biol, 99, 179a.
  212. Hageman GS, Johnson LV (1984). Comparative analysis of peanut agglutinin-binding glycoproteins in vertebrate retinae [Abstract]. J Cell Biol, 99, 61a.
  213. Hageman GS, Johnson LV (1984). Biochemical characterization and morphological localization of lectin-binding glycoproteins in the vertebrate vitreous body and inner limiting membrane [Abstract]. Sixth International Congress of Eye Research, Proc Int Soc Eye Res, 3, 85.
  214. Hageman GS, Johnson LV (1984). Identification and localization of vitreous body glycoproteins using lectin probes [Abstract]. Invest Ophthalmol Vis Sci Suppl, 25, 317.
  215. Johnson LV, Hageman GS (1984). Restricted extracellular matrix domains ensheath cone photoreceptors in vertebrate retinae [Abstract]. Sixth International Congress of Eye Research, Proc Int Soc Eye Res, 3, 12.
  216. Anat Rec (1984). Fibrillar and cytoskeletal organization of single-stranded tight junctions: Freeze-fracture analysis of hamster choroidal fibroblasts [Abstract]. Hageman GS, Kelly DE, 208, 67-68a.
  217. Johnson LV, Hageman GS, Blanks JC (1984). Restricted domains of interphotoreceptor matrix ensheath vertebrate cone photoreceptors [Abstract]. J Cell Biol, 99, 61a.
  218. Johnson LV, Blanks JC, Hageman GS (1984). Characterization of the major peanut-agglutinin-binding glycoprotein in the chick retina [Abstract]. Invest Ophthalmol Vis Sci Suppl, 25, 58.
  219. Hageman GS, Kelly DE (1983). Cytoskeletal support and anchorage of the choriocapillaris [Abstract]. Invest Ophthalmol Vis Sci Suppl, 24, 141.
  220. Hageman GS (1983). Unique pattern of differentiation and distribution of gap junctions between developing oocytes and follicle cells [Abstract]. J Cell Biol, 97, 81a.
  221. Kelly DE, Hageman GS (1983). Fibroblastic occluding junctions in the lamina fusca: A freeze-fracture analysis [Abstract]. Invest Ophthalmol Vis Sci Suppl, 24, 141.
  222. Kelly DE, Hageman GS, McGregor JA (1982). Ultrastructural evidence for potential compartmentation separating anterior and posterior uveal outflow pathways in the hamster eye [Abstract]. Invest Ophthalmol Vis Sci Suppl, 22, 5.
  223. Hageman GS (1981). Accessory reproductive structures in the bryozoan Membranipora serrilamella: A fine structural study of the intertentacular organ [Abstract]. G. P. Larwood and C. Nielson (eds). Recent and Fossil Bryozoa, Olsen and Olsen, Fredensborg, Denmark, 311.
  224. Hageman GS, Wood RL (1981). Homocellular and heterocellular gap junctions in a marine bryozoan [Abstract]. J Cell Biol, 91, 112a.
  225. Hageman GS, Zimmer RL (1980). Accessory reproductive structures in the bryozoan Membranipora serrilamella: Ultrastructure of the pharyngeal gutter [Abstract]. Amer Zool, 20, 750.

Other

  1. Hageman GS (1983). A Fine Structural Analysis of Ovarian Morphology, Oogenesis, and Ovulation in the Marine Bryozoan Membranipora serrilamella (Cheilostomata, Anasca). (pp. 1-488). University of Southern California, Los Angeles, California.